Stryker Corporation $SYK Position Trimmed by Chevy Chase Trust Holdings LLC

Chevy Chase Trust Holdings LLC decreased its holdings in Stryker Corporation (NYSE:SYK) by 3.2% during the third quarter, Holdings Channel.com reports. The firm owned 186,907 shares of the medical technology company’s stock after selling 6,176 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in Stryker were worth $69,094,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. Circle Wealth Management LLC acquired a new stake in shares of Stryker during the third quarter worth approximately $430,000. Clark Capital Management Group Inc. increased its stake in Stryker by 7.0% in the 3rd quarter. Clark Capital Management Group Inc. now owns 212,665 shares of the medical technology company’s stock valued at $78,616,000 after buying an additional 13,876 shares during the period. Ausdal Financial Partners Inc. lifted its position in Stryker by 211.7% in the 3rd quarter. Ausdal Financial Partners Inc. now owns 1,599 shares of the medical technology company’s stock worth $591,000 after buying an additional 1,086 shares in the last quarter. California Public Employees Retirement System lifted its position in Stryker by 16.0% in the 3rd quarter. California Public Employees Retirement System now owns 848,186 shares of the medical technology company’s stock worth $313,549,000 after buying an additional 116,733 shares in the last quarter. Finally, Chilton Investment Co. Inc. boosted its stake in shares of Stryker by 10.0% during the 3rd quarter. Chilton Investment Co. Inc. now owns 3,363 shares of the medical technology company’s stock valued at $1,243,000 after buying an additional 306 shares during the period. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the transaction, the director directly owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. This trade represents a 9.23% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 5.90% of the company’s stock.

Analyst Ratings Changes

SYK has been the topic of a number of research reports. UBS Group upped their price target on shares of Stryker from $386.00 to $400.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 24th. BTIG Research lifted their price objective on Stryker from $410.00 to $412.00 and gave the company a “buy” rating in a research report on Friday, January 30th. Needham & Company LLC boosted their target price on Stryker from $448.00 to $454.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Sanford C. Bernstein upped their target price on Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a research report on Friday, January 9th. Finally, Barclays reiterated an “overweight” rating and set a $469.00 price target on shares of Stryker in a report on Monday, February 2nd. Fourteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $428.61.

Stryker Stock Down 0.1%

Stryker stock opened at $336.95 on Friday. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. Stryker Corporation has a 1-year low of $328.23 and a 1-year high of $404.87. The firm’s fifty day simple moving average is $365.20 and its 200-day simple moving average is $367.52. The company has a market capitalization of $128.95 billion, a P/E ratio of 40.11, a P/E/G ratio of 1.97 and a beta of 0.85.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping the consensus estimate of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The firm had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.12 billion. During the same period in the prior year, the business posted $4.01 earnings per share. The business’s quarterly revenue was up 11.4% on a year-over-year basis. Sell-side analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. Stryker’s dividend payout ratio is currently 41.90%.

More Stryker News

Here are the key news stories impacting Stryker this week:

• Positive Sentiment: Citi and some analysts view the pullback as a potential buying opportunity given Stryker’s fundamentals and upcoming catalysts — Citi put together a “90‑day catalyst watch” that sees upside despite the outage. Citi Sees Upside
• Positive Sentiment: Technicals may offer support: commentators note shares became oversold after the sell‑off and found support at a prior level, suggesting a possible technical bounce for traders. Stock Of The Day: Where Is The Bottom For Stryker?
• Neutral Sentiment: Stryker has publicly confirmed a cybersecurity incident and is investigating; the company is communicating updates as the situation evolves. Company Announcement
• Neutral Sentiment: Reporting shows the attack is causing real operational disruption to order processing, manufacturing and shipments — facts investors must watch to judge duration and revenue impact. Reuters: Disruption Report
• Negative Sentiment: Hackers claiming Iran linkage (group “Handala”) say the attack included destructive “wiper” activity and exfiltration of large volumes of data — allegations that raise the risk of extended downtime and regulatory/PR fallout. IBTimes: Hacker Claim
• Negative Sentiment: Operational paralysis from the incident has already pressured the stock, with multiple outlets reporting multi‑percent intraday declines as orders and shipments stall. Yahoo: Shares Fall
• Negative Sentiment: Social‑media driven selling amplified volatility — a viral Reddit thread and related headlines accelerated the recent drop, adding short‑term downside risk beyond fundamentals. 24/7 Wall St.: Reddit Impact

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.